2023-08-01 17:35:59 ET
- Castle Biosciences ( NASDAQ: CSTL ) is scheduled to announce Q2 earnings results on Wednesday, August 2nd, after market close.
- The consensus EPS Estimate is -$0.91 (-1416.7% Y/Y) and the consensus Revenue Estimate is $44.24M (+27.1% Y/Y).
- Over the last 1 year, CSTL has beaten EPS estimates 50% of the time and has beaten revenue estimates 100% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 3 downward. Revenue estimates have seen 8 upward revisions and 0 downward.
For further details see:
Castle Biosciences Q2 2023 Earnings Preview